Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Liver international (Print)

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2011.02498.xPMID 21745273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hand grip strength: outcome predictor and marker of nutritional status.

  2011cited by this paper
• Sarcopenia associated with portosystemic shunting is reversed by follistatin.

  2011cited by this paper
• Sarcopenia and mortality after liver transplantation.

  2010influential reference
• Gastroduodenal motility

  2010cited by this paper
• Signaling pathways perturbing muscle mass

  2010cited by this paper
• Insulin sensitivity and body composition in cirrhosis: changes after TIPS.

  2010cited by this paper
• Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference

  2010cited by this paper
• Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.

  2010cited by this paper
• Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C

  2010cited by this paper
• Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

  2010cited by this paper
• Early use of TIPS in patients with cirrhosis and variceal bleeding.

  2010influential reference
• The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis.

  2009cited by this paper
• Carla Task Force on Sarcopenia: Propositions for clinical trials

  2009cited by this paper
• Alterations of protein turnover underlying disuse atrophy in human skeletal muscle.

  2009cited by this paper
• Transjugular intrahepatic portosystemic shunt: an analysis of outcomes

  2009cited by this paper
• Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis.

  2009cited by this paper
• Sarcopenia: Clinical evaluation, biological markers and other evaluation tools

  2009cited by this paper
• Body composition determination by bioimpedance: an update

  2009cited by this paper
• The emerging role of computerized tomography in assessing cancer cachexia

  2009cited by this paper
• Protein–calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension

  2009cited by this paper
• Nutrition in end-stage liver disease: principles and practice.

  2008influential reference
• Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.

  2008cited by this paper
• Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

  2007cited by this paper
• Altered expression of genes regulating skeletal muscle mass in the portacaval anastomosis rat.

  2007cited by this paper
• Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study.

  2007cited by this paper
• Two-component models are of limited value for the assessment of body composition in patients with cirrhosis 1 3

  2006influential reference
• Nutritional effects of transjugular intrahepatic portosystemic shunt--an often neglected benefit? "A preliminary report".

  2006cited by this paper
• Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis

  2006cited by this paper
• Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.

  2005cited by this paper
• Is portal hypertension associated with protein‐losing enteropathy?

  2005cited by this paper
• Branched-chain amino acid supplementation in patients with liver diseases.

  2005cited by this paper
• Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites.

  2005cited by this paper
• Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism.

  2004influential reference
• Bioelectrical impedance analysis--part I: review of principles and methods.

  2004cited by this paper
• Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastamosis rat.

  2004cited by this paper
• Gastroduodenal motility.

  2003cited by this paper
• Evaluation of factors determining the precision of body composition measurements by air displacement plethysmography

  2003cited by this paper
• TIPS implantation raises leptin levels in patients with liver cirrhosis.

  2003cited by this paper
• Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis.

  2002cited by this paper
• Preservation of Portal Pressure Improves Growth and Metabolic Profile in the Male Portacaval-Shunted Rat

  2002cited by this paper
• Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis

  2002cited by this paper
• Bioelectrical Impedance to Estimate Changes in Hydration Status

  2002cited by this paper
• Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites

  2001influential reference
• Nutritional assessment in various stages of liver cirrhosis.

  2001cited by this paper
• Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt.

  2000cited by this paper
• Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy X-ray absorptiometry.

  2000cited by this paper
• Evaluation of the strength-size relationship in vivo using various muscle size indices.

  2000cited by this paper
• Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites

  2000cited by this paper
• New techniques in nutritional assessment: Body composition methods

  1999cited by this paper
• Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion

  1998cited by this paper
• Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score

  1998cited by this paper
• Insulin-like growth factor 1 stimulates protein synthesis and inhibits protein breakdown in muscle from burned rats.

  1997cited by this paper
• The potential role of dual-energy X-ray absorptiometry in the assessment of body composition in cirrhotic patients.

  1997cited by this paper
• Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertension.

  1996cited by this paper
• Effect of transjugular intrahepatic portosystemic shunt on quality of life.

  1996cited by this paper
• A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis.

  1994cited by this paper
• Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis.

  1994cited by this paper
• Soft tissue segmentation of the body and fractionation of the upper and lower limbs.

  1994cited by this paper
• Nutritional status in liver cirrhosis.

  1993cited by this paper
• Bioelectrical impedance assessment of nutritional status in critically ill patients.

  1993cited by this paper
• Body cell mass and leucine metabolism in cirrhosis.

  1992cited by this paper
• Postoperative course after portacaval anastomosis in rats is determined by the portacaval pressure gradient.

  1991cited by this paper
• Skeletal muscle and whole-body protein turnover in cirrhosis.

  1990cited by this paper
• Techniques of Measurement of Body Composition Part I

  1988cited by this paper
• Human Body Composition

  1987cited by this paper
• Measurement of lean body mass and total body fat using dual photon absorptiometry.

  1986cited by this paper
• Leucine metabolism in stable cirrhosis

  1986cited by this paper
• Sports science and body composition analysis: emphasis on cell and muscle mass.

  1984cited by this paper
• Factor analysis and multivariate scaling of anthropometric variables for the assessment of body composition.

  1976cited by this paper
• An anthropometric estimation of body density and lean body weight in young men.

  1969cited by this paper
• ANTHROPOMETRIC EVALUATION OF BODY COMPOSITION THROUGHOUT LIFE

  1963cited by this paper

• Post‐TIPS Overt Hepatic Encephalopathy Increases Long‐Term but Not Short‐Term Mortality in Cirrhotic Patients With Variceal Bleeding: A Large‐Scale, Multicenter Real‐World Study

  2025cites this paper
• Association Between Transjugular Intrahepatic Shunt (TIPS) and Waitlist Outcomes in Simultaneous Liver Kidney (SLK) Transplant Candidates

  2025cites this paper
• Long-term outcomes of early transjugular intrahepatic portosystemic shunts in patients with acute variceal bleeding and cirrhosis

  2025cites this paper
• Optimal Patient Selection for TIPS

  2025cites this paper
• Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt

  2024cites this paper
• Effect of TIPS insertion on waitlist mortality and access to liver transplantation in Budd-Chiari syndrome

  2024cites this paper
• Recent developments in the management of ascites in cirrhosis

  2024cites this paper
• Adverse events after the transjugular intrahepatic portal shunt are linked to serum metabolomic changes following the procedure

  2023cites this paper
• Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.

  2023cites this paper
• Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.

  2023cites this paper
• Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt

  2023cites this paper
• Transjugular intrahepatic portosystemic shunt insertion improves muscle mass but not muscle function or frailty measures

  2023cites this paper
• Cirrhosis and Sarcopenia

  2023cites this paper
• Role of Machine Learning-Based CT Body Composition in Risk Prediction and Prognostication: Current State and Future Directions

  2023cites this paper
• Clinical characteristics of hepatopulmonary syndrome and hepatorenal syndrome and associated therapeutic potential of transjugular intrahepatic portosystemic shunt

  2023cites this paper
• Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.

  2023cites this paper
• Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury

  2023cites this paper
• The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

  2022cites this paper
• Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions

  2022cites this paper
• Mitigation of Sarcopenia after Denver Shunt Placement in Patients with Refractory Ascites.

  2022cites this paper
• Predictors of Improvement of Sarcopenia after TIPS Creation in Cirrhotic Patients.

  2022cites this paper
• Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model

  2022cites this paper
• Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction

  2022cites this paper
• Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.

  2022cites this paper
• Nutraceuticals for the treatment of sarcopenia in chronic liver disease.

  2021cites this paper
• The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

  2021cites this paper
• History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites

  2021cites this paper
• Nutritional Management of Sarcopenia in Chronic Liver Disease

  2021cites this paper
• Malnutrition in Patients with Liver Cirrhosis

  2021cites this paper
• Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant.

  2021cites this paper
• Low psoas muscle index associates with long-term mortality in cirrhosis: construction of a nomogram

  2020cites this paper
• Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis.

  2020cites this paper
• Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion

  2020cites this paper
• Improvement in Quality of Life and Decrease in Large‐Volume Paracentesis Requirements With the Automated Low‐Flow Ascites Pump

  2020cites this paper
• Review article: prognostic significance of body composition abnormalities in patients with cirrhosis

  2020cites this paper
• Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update

  2020cites this paper
• Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease

  2020cites this paper
• Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges

  2020cites this paper
• TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis—Authors’ reply

  2020cites this paper
• Malnutrition, sarcopenia, and refractory ascites in end stage liver diseases: is there a way to climb back up?

  2019cites this paper
• Adipopenia correlates with higher portal pressure in patients with cirrhosis

  2019cites this paper
• Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.

  2019cites this paper
• The Pathogenesis of Physical Frailty and Sarcopenia

  2019cites this paper
• Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis

  2019cites this paper
• The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS

  2019cites this paper
• Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease

  2019cites this paper
• Hepatic Ascites in Liver Cirrhosis

  2019cites this paper
• Sarcopenia in cirrhosis: from pathogenesis to interventions

  2019cites this paper
• Nutritional Assessment and Management for Hospitalized Patients with Cirrhosis

  2018cites this paper
• Liver transplantation and alcoholic liver disease: History, controversies, and considerations

  2018cites this paper
• Management of refractory cirrhotic ascites: challenges and solutions

  2018cites this paper
• Fat‐free muscle mass in magnetic resonance imaging predicts acute‐on‐chronic liver failure and survival in decompensated cirrhosis

  2018cites this paper
• Circulating fibroblast growth factor 21 in patients with liver cirrhosis

  2018cites this paper
• Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis

  2017cites this paper
• Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.

  2017cites this paper
• Adipokines in Liver Cirrhosis

  2017influential citation
• Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement

  2017cites this paper
• Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.

  2017cites this paper
• Le TIPS réalisé avec prothèse couverte améliore la survie sans transplantation des patients atteints d'une cirrhose compliquée d'une ascite récidivante : résultats d'une étude randomisée multicentrique

  2016cites this paper
• Cause and management of muscle wasting in chronic liver disease

  2016cites this paper
• Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease.

  2016cites this paper
• Nutrition and Alcoholic Liver Disease: Effects of alcoholism on nutrition, Effects of nutrition on ALD and Nutritional therapies for ALD

  2016cites this paper
• Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients With Cirrhosis.

  2016cites this paper
• Sarcopenia from mechanism to diagnosis and treatment in liver disease.

  2016cites this paper
• Role of Comorbidities in the General Management of Compensated Cirrhosis, Including Malnutrition

  2016cites this paper
• Challenges and opportunities in the management of portal hypertension

  2015cites this paper
• Factors related to increased resting energy expenditure in men with liver cirrhosis

  2015cites this paper
• Change in skeletal muscle mass after administering entecavir in patients with hepatitis B.

  2015cites this paper
• Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation

  2014cites this paper
• Treatment to Improve Nutrition and Functional Capacity Evaluation in Liver Transplant Candidates

  2014cites this paper
• Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent

  2013cites this paper
• The insulin like growth factor system in cirrhosis. Relation to changes in body composition following adrenoreceptor blockade.

  2012cites this paper